Showing results (1771-1780 of 1,877) with videos related to

Sort By:
Pageof 188
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experienceHervé Avet-Loiseau, Cyrille Hulin, Loic Campion, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2022
An artificial intelligence model predicts the survival of solid tumour patients from imaging and clinical dataKathryn Schutte, Fabien Brulport, Sana Harguem-Zayani, et al.
Leukemia|July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patientsB Hebraud, X Leleu, V Lauwers-Cances, et al.
Plos Neglected Tropical Diseases|June 16, 2017
Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy casesMariane M A Stefani, Charlotte Avanzi, Samira Bührer-Sékula, et al.
Blood|July 21, 2021
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIAMichele Cavo, Jesus San-Miguel, Saad Z Usmani, et al.
Nature Communications|August 25, 2019
Genomic landscape and chronological reconstruction of driver events in multiple myelomaFrancesco Maura, Niccoló Bolli, Nicos Angelopoulos, et al.
Blood Cancer Discovery|January 4, 2021
Revealing the impact of structural variants in multiple myelomaEven H Rustad, Venkata D Yellapantula, Dominik Glodzik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2017
Prospective Evaluation of Magnetic Resonance Imaging and [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM StudyPhilippe Moreau, Michel Attal, Denis Caillot, et al.
Annals of Hematology|January 14, 2018
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myelomaGuillemette Fouquet, Lionel Karlin, Margaret Macro, et al.
Scientific Reports|November 16, 2017
ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartmentsYu Wu, Valérie Pons, Amélie Goudet, et al.
Pageof 188